Tricalcium Phosphate.
A calcium and phosphorus source that doubles as an anti-caking agent. Gets both jobs done, neither amazingly. Provides calcium and phosphorus for bone health.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- Calcium source (39% elemental)Phosphorus sourceAnti caking agent
What Tricalcium Phosphate is, and what it does.
- How much to take
- 500-1200mg of elemental calcium daily (from 1300-3100mg of tricalcium phosphate). Split doses above 500mg.
- Time to feel it
- Calcium runs on a long clock. Nothing registers in the first weeks, and bone density changes are measured over months to years on a scan.
- The first dose
- Nothing dramatic. Calcium works quietly over months.
- With regular use
- Supports bone mineral density when taken consistently over months to years.
- How well tolerated
- Well tolerated at recommended doses. Don't exceed 2500mg calcium daily from all sources.
- How it feels
- You don't feel calcium working. The benefits show up in bone density scans.
- The overlooked benefit
- It brings phosphate as well as calcium, in a three to two ratio, and both of those ions are literally what bone mineral is built from.
500 to 1,200mg a day is where Tricalcium Phosphate works.
Source: IOM Calcium DRI 2011; Heaney RP et al. J Am Coll Nutr. 2001
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Supports bone health
- Absorption is comparable to calcium carbonate
- Works as an anti-caking agent
Questions people ask about Tricalcium Phosphate.
- Why is this listed as 'other ingredients'?
- When used as an anti-caking agent, it's at doses too small for nutritional impact. It's doing a different job there.
- Can I get too much phosphorus from this?
- Unlikely from supplements alone. But if you have kidney disease, monitor your total phosphorus intake.
- Should I split my calcium dose?
- Yes. Your body absorbs calcium best in amounts of 500mg or less at a time. Take larger doses in two sittings.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Calcitriol induces the intestinal calcium channels and binding proteins that move calcium across the gut wall, and it raises phosphate absorption as well. Both halves of tricalcium phosphate depend on vitamin D status.
Vitamin K2 carboxylates osteocalcin and matrix Gla protein, the proteins that bind calcium into bone matrix and keep it out of soft tissue. Calcium intake without K2 leaves those proteins undercarboxylated.
Calcium and magnesium share intestinal transport routes and phosphate binds magnesium in the gut lumen, so a large calcium phosphate dose lowers magnesium uptake taken at the same time. Magnesium is also required to activate vitamin D, which calcium absorption depends on.
Calcium blunts non-heme iron uptake at the enterocyte, and phosphate forms poorly soluble complexes with iron in the gut. Separating the two doses by a few hours preserves iron uptake.
Ferrous iron and calcium interfere at shared absorption steps, and phosphate anions precipitate iron salts in the intestinal lumen. Co-dosing lowers the iron actually absorbed.
Calcium and phosphate together reduce zinc absorption by forming insoluble complexes in the gut. High calcium phosphate intakes are a known reason to dose zinc separately.
Strontium and calcium are chemically similar divalent cations that compete for the same intestinal transport and the same bone mineral sites. They belong at separate times of day.
Tricalcium phosphate is a calcium salt, so it counts toward the same total calcium intake as any other calcium source. Stacking simply raises the load.
Phytate chelates calcium and holds phosphorus in a form humans absorb poorly, and phytase hydrolyses it. Adding phytase to a plant-heavy meal releases both minerals for uptake.
Balance studies report that boron intake alters urinary loss of calcium and magnesium, which puts it upstream of how a calcium salt is retained rather than absorbed. The measurements are of mineral balance, a marker of handling, not of bone structure. Modest evidence base, which keeps this at Promising.
Bone is a mineral phase deposited on a collagen scaffold, and silicon is discussed in reference literature as contributing to that organic phase. Tricalcium phosphate supplies the mineral side only. The pairing addresses two components of the same tissue, with the silicon evidence weaker than the calcium evidence.
Copper shares intestinal handling routes with other divalent metals, and a gram-scale calcium dose in the same lumen reduces copper uptake from that meal. Copper is also required by lysyl oxidase for bone collagen cross-linking, so the competition sits on a pathway bone depends on. Separating a high-dose calcium serving from a copper-containing multivitamin is the practical response.
Manganese absorption falls when a large calcium load is present in the same meal, a well described divalent mineral interaction. Manganese is itself a cofactor for glycosyltransferases in cartilage matrix synthesis. Dose timing, not dose size, is what resolves this.
Caffeine has a measurable calciuric effect, raising urinary calcium output for several hours after a dose. That acts on retention rather than absorption, so it is not fixed by taking the calcium at a different time of day. The size of the effect is small relative to total intake, which is why it matters most where intake is already low.
Higher sodium intake increases urinary calcium loss because the two compete in tubular reabsorption. This is settled renal physiology and again affects retention rather than uptake. It means the calcium balance a supplement supports depends partly on the rest of the diet.
Calcium must be released as free ion before it can be absorbed, and an insoluble phosphate salt depends on gastric acid to do that. Where gastric acid output is low, an acid-independent form or a supplemental acid source changes the dissolution step. This is chemistry of dissolution and says nothing about a total absorption figure.
Fermentation of inulin produces short chain fatty acids that lower luminal pH in the colon, which keeps calcium in solution further along the tract and has been associated with higher measured calcium absorption. The endpoint in that work is fractional absorption, a marker, not bone outcome. The effect is described for calcium generally rather than for this salt specifically.
Short chain fructans ferment earlier in the colon and produce the same acidification that keeps calcium soluble. Studies in this area report fractional calcium absorption rather than skeletal endpoints. Chain length changes where in the colon the effect occurs.
Galactooligosaccharides ferment to short chain fatty acids and have been examined for their effect on measured calcium absorption. As with the other prebiotics, the outcome measured is an absorption marker. Gas and bloating at higher doses is the trade-off worth naming.
Lysine has been described as increasing calcium uptake across intestinal preparations and reducing urinary calcium loss. The work is limited and largely older or preclinical. Early, and included because it is a real reported interaction rather than a formulation habit.
An acidic environment favours dissolution of tricalcium phosphate to free calcium and phosphate ions. Co-ingesting an acidic vitamin contributes marginally to that condition. The effect is small next to gastric acid itself, so this is a minor handling note.
A viscous gel-forming fibre traps dissolved minerals and slows their contact with the absorptive surface, so a large psyllium dose taken with a calcium salt reduces uptake from that serving. Separating the two by a couple of hours resolves it. This applies to minerals generally rather than to phosphate salts in particular.
Bentonite is a cation-exchange material and readily binds calcium and other divalent ions in the gut lumen. Taken together with a calcium supplement it reduces what is available for absorption. This is ion-exchange chemistry, not a speculative interaction.
Activated charcoal adsorbs a broad range of co-ingested substances and its surface chemistry does not discriminate in favour of nutrients. A supplement taken in the same window is partly adsorbed. Dose separation is the standard handling instruction for any charcoal product.
Tricalcium phosphate supplies the mineral constituents of bone in roughly the ratio bone mineral uses them, while collagen peptides supply the amino acids of the organic scaffold. Combining the two mirrors the composition of the tissue. Note that collagen's hydroxyproline load raises urinary oxalate, which binds calcium in the lumen, so the pairing has a competing element as well.
Alanine glyoxylate aminotransferase is a pyridoxal-5-phosphate enzyme that decides whether glyoxylate returns to glycine or is oxidised to oxalate. Oxalate then binds calcium in the gut and in urine. That places B6 status upstream of how much oxalate a calcium load will encounter, which is settled cofactor biochemistry.
Talk to a doctor before taking Tricalcium Phosphate if any of these apply to you: Lower bioavailability than calcium citrate, Needs stomach acid for absorption, Kidney stone risk at very high calcium doses. These are flags to check first, not effects Tricalcium Phosphate is known to cause.
Not medical advice. Show the label to your pharmacist.What Tricalcium Phosphate actually does.
Tricalcium phosphate is a calcium and phosphate compound, so each dose delivers both minerals together rather than calcium on its own.
Actual calcium makes up roughly 38 to 39 percent of tricalcium phosphate's weight, which is why the total compound weight and the calcium weight on a label are different numbers.
This compound dissolves poorly in water, and how well it breaks apart into free calcium and phosphate depends on acidity, so stomach acid is what makes its calcium available for absorption.
Calcium gets absorbed by two routes. One depends on active vitamin D, dominates at low intake, and can max out. A simpler route dominates at high intake and doesn't max out.
Getting Tricalcium Phosphate from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- An open-label report on tolerability of stromal vascular fraction combined with beta-tricalcium phosphate in posterior lumbar interbody fusion. The material was implanted at a surgical site, which says nothing about oral intake of tricalcium phosphate as a nutrient.Open-label trial. Choi UY et al., 2020 (Cells). PMID 33049918 ↗
- A mid-term follow-up series reports bony union rates in arthrodesis procedures using a synthetic graft containing beta-tricalcium phosphate. This is a surgical implant outcome, not a dietary supplement outcome.Cohort study. O'Neill C et al., 2026 (Foot and Ankle Specialist). PMID 41784067 ↗
- A clinical series reports that a bone graft substitute achieved posterior spinal fusion in adolescent patients. Tricalcium phosphate appears as a component of graft materials discussed rather than as the studied variable.Cohort study. Paez CJ et al., 2026 (Journal of Spine Surgery). PMID 42294379 ↗
- A narrative review of bone graft selection in spinal fusion describes where synthetic calcium phosphate ceramics including tricalcium phosphate sit among graft options. It is a surgical materials review.Narrative review. Miyazaki M et al., 2026 (Spine Surgery and Related Research). PMID 42292577 ↗
- Adding glucose oxidase to an alpha-tricalcium phosphate and honey biocement increased its antibacterial activity in laboratory testing. A bench materials-science result about a cement, not about ingestion.In vitro study. Medvecky L et al., 2026 (International Journal of Biological Macromolecules). PMID 41534807 ↗
- A comparison of bone regeneration in critical-sized defects in animals included beta-tricalcium phosphate among the tested scaffold materials. An animal implant model, not oral supplementation.Animal study. Yamauchi I et al., 2025 (Nagoya Journal of Medical Science). PMID 41140815 ↗
- A trial of an oral alpha lipoic acid and B complex preparation names tricalcium phosphate only as a formulation component. It provides no evidence about the mineral itself.Randomised trial. Zainal NA et al., 2025 (BMC Neurology). PMID 41361445 ↗
These are the studies our verdict leans on, chosen from the 7 we read for Tricalcium Phosphate. The full linked list is below.
The studies, linked.
11 sources behind our Tricalcium Phosphate verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEffectiveness of Biannual Application of Silver Nitrate Solution Followed by Sodium Fluoride Varnish With or Without Functionalized Tricalcium Phosphate in Arresting Caries in Preschool ChildrenClinicalTrials.gov ↗Phase 3, 408 participants, Completed
- Clinical trialA National, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute in Filling of Contained Bone DefectsClinicalTrials.gov ↗120 participants, Completed
- Clinical trialMaxillary Sinus Augmentation With Three Different Biomaterials: Histologic, Histomorphometric, Clinical and Patient Reported Outcomes From a Randomized Controlled TrialClinicalTrials.gov ↗Phase 4, 24 participants, Completed
- Clinical trialPhase II Clinical Trial of Tissue Engineering Based on the Use of Mononuclear Cells From Autologous Bone Marrow Seeded on Porous Tricalcium Phosphate Biomaterial in Patients With PseudoarthrosisClinicalTrials.gov ↗Phase 2, 5 participants, Completed
- Clinical trialClinical Efficacy of Easy-graft CLASSIC for the Treatment of Peri-implantitisClinicalTrials.gov ↗5 participants, Terminated
- Clinical trialA Prospective Randomized Controlled Trial for Prevention of Enamel White Spot Lesions During Fixed Orthodontic TreatmentClinicalTrials.gov ↗Phase 2, 99 participants, Unknown
- Clinical trialEvaluation of Silicate-Added Beta-Tricalcium Phosphate Putty in Fully-Guided Immediate Implants in the Esthetic Zone Using Customized Healing AbutmentClinicalTrials.gov ↗72 participants, Active not recruiting
- Clinical trialMinimally Invasive Treatment Approach for Early Childhood Caries Using Silver Diammine Fluoride and Sodium Fluoride With Functionalized Tricalcium Phosphate and Their Effects on Oral Health Related Quality of Life: A Pragmatic Randomized Control TrialClinicalTrials.gov ↗Phase 4, 72 participants, Unknown
- Clinical trialMinimally Invasive Non-surgical Therapy With or Without Injectable Bone Putty in Treating Intra-bony Periodontal Defects (Randomized Controlled Clinical Trial)ClinicalTrials.gov ↗Phase 3, 30 participants, Unknown
- Clinical trialPhase I Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis (MSC/ONM)ClinicalTrials.gov ↗Phase 1, 10 participants, Unknown
- Clinical trialCalcaneal Neck Lengthening Osteotomy - Allogen Bone Graft Material Versus a Hydroxyapatite / β- Tricalcium Phosphate Bone SubstituteClinicalTrials.gov ↗10 participants, Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 64 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Tricalcium Phosphate is, not how risky it is. A report is not proof Tricalcium Phosphate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.

